Tenax Therapeutics, Inc.TENXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+61.1%
5Y CAGR+35.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+61.1%/yr
vs +0.1%/yr prior
5Y CAGR
+35.5%/yr
Recent acceleration
Acceleration
+61.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $23.71M | +249.5% |
| 2024 | $6.79M | +35.6% |
| 2023 | $5.00M | -11.8% |
| 2022 | $5.68M | -25.1% |
| 2021 | $7.58M | +46.0% |
| 2020 | $5.19M | +2.1% |
| 2019 | $5.08M | -10.1% |
| 2018 | $5.65M | -0.4% |
| 2017 | $5.68M | -9.1% |
| 2016 | $6.25M | - |